Rectal Cancer | PETACC 6
A study of preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer.
Schema
Summary
The PETACC 6 study is an EORTC-led open-label, randomised, multi-national, two-arm phase III study investigating whether the addition of oxaliplatin to preoperative fluoropyrimidine-based chemoradiation and postoperative fluoropyrimidine-based chemotherapy improves disease-free survival in locally.
